3460-11-5Relevant articles and documents
Amidation of aryl halides catalyzed by silica-supported bidentate phosphine palladium complex
Cai, Ming-Zhong,Song, Cai-Sheng,Huang, Xian
, p. 361 - 366 (1997)
A silica-supported bidentate phosphine palladium complex was prepared from poly-4-oxa-6,7-bis(diphenylphosphino)heptyl siloxane and palladium chloride in acetone. It was an efficient catalyst for the amidation of aryl halides with carbon monoxide and aniline at 1 atm pressure, affording aryl amides.
Cyclic hydroxamic acids as oxygenating agents - Conversion of imines to anilides
Sahadeva Reddy,Pratap Reddy,Reddy
, p. 3447 - 3451 (2001)
Cyclic hydroxamic acid mediated functional group modification of an imine to anilide is reported.
Iron-catalyzed oxidative amidation of acylhydrazines with amines
Wang, Yi-Jie,Zhang, Guo-Yu,Shoberu, Adedamola,Zou, Jian-Ping
supporting information, (2021/08/18)
A new approach for amide bond formation via a mild and efficient Iron-catalyzed cross-coupling reaction of acylhydrazines and amines using TBHP as oxidant is described. This protocol is compatible with a wide range of amines and acylhydrazines. In addition, the synthetic application of the reaction is presented.
Structure-Based Optimization of Quinazolines as Cruzain and TbrCATL Inhibitors
Barbosa Da Silva, Elany,Rocha, Débora A.,Fortes, Isadora S.,Yang, Wenqian,Monti, Ludovica,Siqueira-Neto, Jair L.,Caffrey, Conor R.,McKerrow, James,Andrade, Saulo F.,Ferreira, Rafaela S.
, p. 13054 - 13071 (2021/09/13)
The cysteine proteases, cruzain and TbrCATL (rhodesain), are therapeutic targets for Chagas disease and Human African Trypanosomiasis, respectively. Among the known inhibitors for these proteases, we have described N4-benzyl-N2-phenylquinazoline-2,4-diamine (compound 7 in the original publication, 1a in this study), as a competitive cruzain inhibitor (Ki = 1.4 μM). Here, we describe the synthesis and biological evaluation of 22 analogs of 1a, containing modifications in the quinazoline core, and in the substituents in positions 2 and 4 of this ring. The analogs demonstrate low micromolar inhibition of the target proteases and cidal activity against Trypanosoma cruzi with up to two log selectivity indices in counterscreens with myoblasts. Fourteen compounds were active against Trypanosoma brucei at low to mid micromolar concentrations. During the optimization of 1a, structure-based design and prediction of physicochemical properties were employed to maintain potency against the enzymes while removing colloidal aggregator characteristics observed for some molecules in this series.
